UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression ...
According to an article in the June 2022 issue of Psychiatry Research, "Replicated clinical trials have demonstrated rapid and robust antidepressant effects with ketamine in treatment-resistant ...
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...
Kabir Nigam [Opens in a new window], Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for ...